Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-10-31 4:26 pm Purchase | 2023-10-30 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Point72 Asset Management, L.P. | 3,520,402 5.100% | 3,520,402 (New Position) | Filing History |
| 2023-10-20 4:15 pm Purchase | 2023-10-19 | 13G | Semtech Corporation SMTC | Point72 Asset Management, L.P. | 4,660,836 7.300% | 4,660,836 (New Position) | Filing History |
| 2023-10-18 4:15 pm Purchase | 2023-10-17 | 13G | Biohaven Ltd. BHVN | Point72 Asset Management, L.P. | 4,061,343 5.100% | 4,061,343 (New Position) | Filing History |
| 2023-10-10 4:59 pm Purchase | 2023-10-09 | 13G | Madison Square Garden Entertainment Corp. MSGE | Point72 Asset Management, L.P. | 2,303,613 5.600% | 2,303,613 (New Position) | Filing History |
| 2023-10-10 4:05 pm Purchase | 2023-09-29 | 13G | Rapid7, Inc. RPD | Point72 Asset Management, L.P. | 3,092,270 5.100% | 3,092,270 (New Position) | Filing History |
| 2023-10-05 4:47 pm Purchase | 2023-10-04 | 13G | VistaGen Therapeutics, Inc. VTGN | Point72 Asset Management, L.P. | 1,565,829 5.600% | 1,565,829 (New Position) | Filing History |
| 2023-10-05 4:24 pm Purchase | 2023-10-04 | 13G | TPI Composites, Inc. TPICQ | Point72 Asset Management, L.P. | 2,132,171 5.000% | 2,132,171 (New Position) | Filing History |
| 2023-10-02 4:45 pm Purchase | 2023-09-29 | 13G | Morphic Holding, Inc. MORF | Point72 Asset Management, L.P. | 2,504,383 5.200% | 2,504,383 (New Position) | Filing History |
| 2023-09-29 4:33 pm Purchase | 2023-09-28 | 13G | Bionomics Limited BNOX | Point72 Asset Management, L.P. | 9,924,390 8.100% | 9,924,390 (New Position) | Filing History |
| 2023-09-18 4:24 pm Purchase | 2023-09-15 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | Point72 Asset Management, L.P. | 3,727,952 5.600% | 3,727,952 (New Position) | Filing History |
| 2023-09-15 5:11 pm Purchase | 2023-09-14 | 13G | Cybin Inc. CYBN | Point72 Asset Management, L.P. | 498,684 8.100% | 498,684 (New Position) | Filing History |
| 2023-07-27 4:20 pm Purchase | 2023-07-25 | 13G | Turnstone Biologics Corp. TSBX | Point72 Asset Management, L.P. | 1,383,314 6.200% | 1,383,314 (New Position) | Filing History |
| 2023-07-27 4:15 pm Purchase | 2023-07-26 | 13G | Health Catalyst, Inc. HCAT | Point72 Asset Management, L.P. | 2,824,930 5.000% | 904,677 (+47.11%) | Filing History |
| 2023-07-20 4:54 pm Purchase | 2023-07-19 | 13G | Chewy, Inc. CHWY | Point72 Asset Management, L.P. | 6,705,883 5.800% | 6,705,883 (New Position) | Filing History |
| 2023-07-20 4:15 pm Purchase | 2023-07-18 | 13G | Caribou Biosciences, Inc. CRBU | Point72 Asset Management, L.P. | 4,085,544 5.100% | 4,085,544 (New Position) | Filing History |
| 2023-06-26 4:30 pm Purchase | 2023-06-21 | 13G | Praxis Precision Medicines, Inc. PRAX | Point72 Asset Management, L.P. | 761,834 8.900% | 687,889 (+930.26%) | Filing History |
| 2023-06-01 5:00 pm Purchase | 2023-05-31 | 13G | Cogent Biosciences, Inc. COGT | Point72 Asset Management, L.P. | 3,562,902 5.000% | 3,562,902 (New Position) | Filing History |
| 2023-05-24 5:15 pm Purchase | 2023-05-17 | 13G | Elevation Oncology, Inc. ELEV | Point72 Asset Management, L.P. | 2,121,170 8.700% | 2,121,170 (New Position) | Filing History |
| 2023-05-16 4:02 pm Purchase | 2023-05-15 | 13G | CUTERA INC CUTRQ | Point72 Asset Management, L.P. | 1,144,407 5.800% | 1,144,407 (New Position) | Filing History |
| 2023-04-05 4:23 pm Purchase | 2023-04-04 | 13G | Esperion Therapeutics, Inc. ESPR | Point72 Asset Management, L.P. | 4,533,756 5.000% | 2,095,618 (+85.95%) | Filing History |